EUVIMEDAtklāt EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

A Review of the Biology of Chikungunya Virus Highlighting the Development of Current Novel Therapeutic and Prevention Approaches

Geovana Martelossi-Cebinelli iD, Jessica A Carneiro iD, Kelly M Yaekashi iD, Mariana M Bertozzi iD, Beatriz H S Bianchini iD, Fernanda S Rasquel-Oliveira iD, Camila Zanluca iD, Claudia N Duarte Dos Santos iD, Rachel Arredondo iD, Tiffani A Blackburn iD, Rubia Casagrande iD, Waldiceu A Verri iD

Pathogens · 2025-10-16 · 14 (10) · 1047

DOI: 10.3390/pathogens14101047 ↗

At a glance

Übersichtsarbeit in Pathogens, published online on 2025-10-16. Written by Geovana Martelossi-Cebinelli and 11 co-authors. Institution: Laboratory of Pain, Inflammation, Neuropathy and Cancer, Department of Immunology, Parasitology, and General Pathology, Londrina State University, Lo…. Major MEDLINE topics: Chikungunya virus, Chikungunya Fever. Cited 18 times so far (Crossref); 408 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Council for Scientific and Technological Development, Fundação Araucária, Conselho Paranaense de Ciência e Tecnologia.

AbstraktsSubjectsBibliogrāfiskie datiCiteRelated studies

Abstract (original language)

Chikungunya virus (CHIKV) is an arthritogenic alphavirus transmitted primarily via Aedes aegypti and Aedes albopictus mosquitoes. Since its identification, CHIKV remained confined to parts of Africa and Asia until the early 2000s, when it expanded to other continents, causing epidemics. Structurally, it is an enveloped virus with a positive-single-stranded RNA genome, which encodes four non-structural proteins (nsP1-nsP4), responsible for viral replication, and five structural proteins (C, E3, E2, 6K, and E1), which form the capsid and envelope. Of these proteins, glycoproteins E1 and E2 are essential for cell recognition and membrane fusion, determining infectivity and viral tropism. CHIKV replication occurs in the cytosol of different cell types, triggering an intense inflammatory and immune response, which manifests clinically as Chikungunya fever (CHIKF). Despite its epidemiological impact, current treatment is limited to symptomatic approaches, including the use of analgesics and anti-inflammatories, as no specific antiviral therapies are available. In response, promising advances are being made, including the development of vaccines, targeted antivirals, and immunotherapies. This article aims to review the main aspects of viral biology, epidemiology, and immunopathogenesis of CHIKV infection, in addition to discussing the main advances in the development of new therapeutic approaches for its control.

Subjects

MeSH terms (MEDLINE)

Chikungunya virusChikungunya FeverHumansAnimalsAntiviral AgentsVirus ReplicationViral Vaccines

Author keywords

alphavirusantiviralsimmunopathologymonoclonal antibodiesvaccines

Substances

Antiviral AgentsViral Vaccines

Authors and institutions

  • Laboratory of Pain, Inflammation, Neuropathy and Cancer, Department of Immunology, Parasitology, and General Pathology, Londrina State University, Londrina 86057-970, Brazil.
  • Department of Pharmaceutical Sciences, Center of Health Science, Londrina State University, Londrina 86057-970, Brazil.
  • Vascular Biology Program, Department of Surgery, Boston Childrens's Hospital-Harvard Medical School, Karp Research Building 1 Blackfan St, Boston, MA 02115, USA.
  • Laboratory of Molecular Virology, Carlos Chagas Institute/Fiocruz Paraná, Curitiba 81310-020, Brazil.

ORCID profiles: Geovana Martelossi-Cebinelli, Jessica A Carneiro, Kelly M Yaekashi, Mariana M Bertozzi, Beatriz H S Bianchini, Fernanda S Rasquel-Oliveira, Camila Zanluca, Claudia N Duarte Dos Santos, Rachel Arredondo, Tiffani A Blackburn, Rubia Casagrande, Waldiceu A Verri

Funding

  • National Council for Scientific and Technological Development
  • Fundação Araucária
  • Conselho Paranaense de Ciência e Tecnologia
  • Financiadora de Estudos e Projetos
  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq
  • SETI/Fundação Araucária and MCTI/CNPq, and Governo do Estado do Paraná
  • Governo do Estado do Paraná, Conselho Paranaense de Ciência e Tecnologia, e Secretaria de Estado da Ciência, Tecnologia, e Ensino Superior

Cite

APA

Martelossi-Cebinelli, G., Carneiro, J. A., Yaekashi, K. M., Bertozzi, M. M., Bianchini, B. H. S., Rasquel-Oliveira, F. S., Zanluca, C., Duarte Dos Santos, C. N., Arredondo, R., Blackburn, T. A., Casagrande, R., & Verri, W. A. (2025). A Review of the Biology of Chikungunya Virus Highlighting the Development of Current Novel Therapeutic and Prevention Approaches. Pathogens, 14(10), 1047. https://doi.org/10.3390/pathogens14101047

Vancouver

Martelossi-Cebinelli G, Carneiro JA, Yaekashi KM, Bertozzi MM, Bianchini BHS, Rasquel-Oliveira FS, et al. A Review of the Biology of Chikungunya Virus Highlighting the Development of Current Novel Therapeutic and Prevention Approaches. Pathogens. 2025;14(10):1047. doi:10.3390/pathogens14101047

BibTeX
@article{MartelossiCebinelli2025,
  author = {Martelossi-Cebinelli, Geovana and Carneiro, Jessica A and Yaekashi, Kelly M and Bertozzi, Mariana M and Bianchini, Beatriz H S and Rasquel-Oliveira, Fernanda S and Zanluca, Camila and Duarte Dos Santos, Claudia N and Arredondo, Rachel and Blackburn, Tiffani A and Casagrande, Rubia and Verri, Waldiceu A},
  title = {A Review of the Biology of Chikungunya Virus Highlighting the Development of Current Novel Therapeutic and Prevention Approaches},
  journal = {Pathogens},
  year = {2025},
  volume = {14},
  number = {10},
  pages = {1047},
  doi = {10.3390/pathogens14101047}
}
Start for free →